Indecainide

Indecainide
Clinical data
ATC code	none;
Identifiers
	IUPAC name 9-[3-(isopropylamino)propyl]-9H-fluorene-9-carboxamide;
CAS Number	74517-78-5 ; 73681-12-6 (HCl);
PubChem CID	52194;
DrugBank	DB00192 ;
ChemSpider	47194 ;
UNII	3AZF20DM1T;
KEGG	D04521 ;
ChEMBL	ChEMBL1201242 ;
CompTox Dashboard (EPA)	DTXSID2057819 ;
Chemical and physical data
Formula	C20H24N2O
Molar mass	308.425 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N)C3(c1ccccc1c2c3cccc2)CCCNC(C)C;
	InChI InChI=1S/C20H24N2O/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23) ; Key:UCEWGESNIULAGX-UHFFFAOYSA-N ;
	(what is this?) (verify)

Indecainide (INN, trade name Decabid) is a class Ic antiarrhythmic agent.^[1] Developed and marketed by Lilly, it has now been discontinued.

References

↑ Jaillon P, Drici M (December 1989). "Recent antiarrhythmic drugs". The American Journal of Cardiology. 64 (20): 65J–69J. doi:10.1016/0002-9149(89)91203-4. PMID 2688391.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by adding missing information.